These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2815230)

  • 1. Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):551-7. PubMed ID: 2815230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):558-66. PubMed ID: 2815231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of diltiazem and its metabolites after repeated multiple-dose treatments in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):543-50. PubMed ID: 2815229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological disposition of intravenously administered 14C-labeled diltiazem in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1988; 10(4):401-9. PubMed ID: 3201524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses.
    Caillé G; Boucher S; Spénard J; Lakhani Z; Russell A; Thiffault J; Grace MG
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):75-80. PubMed ID: 1936065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose.
    Boyd RA; Chin SK; Don-Pedro O; Verotta D; Sheiner LB; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Oct; 46(4):408-19. PubMed ID: 2791444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of diltiazem in patients with liver cirrhosis.
    Kurosawa S; Kurosawa N; Owada E; Soeda H; Ito K
    Int J Clin Pharmacol Res; 1990; 10(6):311-8. PubMed ID: 2099357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses.
    Caillé G; Boucher S; Spénard J; Lakhani Z; Russell A; Thiffault J; Grace MG
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):75-80. PubMed ID: 1936076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.
    Sigusch H; Henschel L; Kraul H; Merkel U; Hoffmann A
    Pharmazie; 1994 Sep; 49(9):675-9. PubMed ID: 7972311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pharmacokinetics, bioavailability and dose linearity of diltiazem in healthy volunteers.
    Hutt V; Janik F; Kappler J; Pabst G; Ravelli V; Maccari M; Jaeger H
    Arzneimittelforschung; 1993 Jul; 43(7):737-43. PubMed ID: 8369005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC; Sams RA; Bonagura JD
    J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.
    Sista S; Lai JC; Eradiri O; Albert KS
    J Clin Pharmacol; 2003 Oct; 43(10):1149-57. PubMed ID: 14517197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules.
    Du Souich P; Lery N; Lery L; Varin F; Boucher S; Vezina M; Pilon D; Spenard J; Caillé G
    Biopharm Drug Dispos; 1990 Mar; 11(2):137-47. PubMed ID: 2328299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers.
    Yeung PK; Montague TJ; Tsui B; McGregor C
    J Pharm Sci; 1989 Jul; 78(7):592-7. PubMed ID: 2778663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of diltiazem in patients undergoing continuous ambulatory peritoneal dialysis.
    Grech-Bélanger O; Langlois S; LeBoeuf E
    J Clin Pharmacol; 1988 May; 28(5):477-80. PubMed ID: 3392246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and multiple oral dose pharmacokinetics of clentiazem in normal volunteers.
    Bhargava VO; Shah AK; Weir SJ; Nordbrock EE; Giesing DH
    J Clin Pharmacol; 1993 May; 33(5):439-43. PubMed ID: 8331200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose.
    Yeung PK; Prescott C; Haddad C; Montague TJ; McGregor C; Quilliam MA; Xei M; Li R; Farmer P; Klassen GA
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):199-206. PubMed ID: 8243504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP; Choi DH; Choi JS
    Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of cimetidine on the pharmacokinetics of diltiazem and its main metabolite in rabbits.
    Choi JS; Burm JP
    Arch Pharm Res; 2004 Feb; 27(2):254-8. PubMed ID: 15022730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.